Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy

Hypertension Research

Volumn 25, Issue 4, 2002, Pages 597-603

  Toko, Haruhiro ^a   Oka, Toru ^a   Zou, Yunzeng ^a   Sakamoto, Masaya ^a   Mizukami, Miho ^a   Sano, Masanori ^a   Yamamoto, Rie ^a   Sugaya, Takeshi ^a   Komuro, Issei ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Angiotensin II type 1 receptor antagonist; Cardiac remodeling; Doxorubicin; Knockout mouse

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTHRACYCLINE DERIVATIVE; DAUNORUBICIN; DOXORUBICIN; OLMESARTAN; ANGIOTENSIN RECEPTOR; ANTINEOPLASTIC AGENT; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOCRINE FUNCTION; GENE EXPRESSION; HEART ARRHYTHMIA; HEART FUNCTION; HEART MUSCLE; HEART VENTRICLE REMODELING; HUMAN; KNOCKOUT MOUSE; MOUSE; MYOCARDITIS; NONHUMAN; PERICARDITIS; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; CELL VACUOLE; CHEMICALLY INDUCED DISORDER; CYTOPLASM; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HEART; HEART MUSCLE CELL; MALE; METABOLISM; MOUSE MUTANT; MUSCLE FIBRIL; PATHOLOGY; PATHOPHYSIOLOGY; REFERENCE VALUE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARDIOMYOPATHIES; CYTOPLASM; DOXORUBICIN; GENE EXPRESSION; HEART; IMIDAZOLES; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; MYOCYTES, CARDIAC; MYOFIBRILS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; REFERENCE VALUES; TETRAZOLES; VACUOLES;

EID: 0035993035     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.597     Document Type: Article

References (33)

1. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats
2. Anthracycline-induced cardiotoxicity
3. Doxorubicin-induced cardiac toxicity
4. Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response
5. Effects of doxorubicin on excitation-contraction coupling in guinea pig ventricular myocardium
6. Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system
7. Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice
8. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension
9. Regression of left ventricular hypertrophy from systemic hypertension by enalapril
10. An angiotensin II type 1 receptor blocker, candesartan, increases myocardial apoptosis in rats with acute ischemiareperfusion
11. Mechanism of the cardioprotective effect of inhibition of the renin-angiotensin system on ischemia/reperfusion-induced myocardial injury
12. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts
13. Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias
14. Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction
15. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia
16. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist
17. Apoptosis in human acute myocardial infarction
18. Apoptosis in the failing human heart
19. MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes
20. Structural and functional impairment of mitochondria in adriamycin-induced cardiomyopathy in mice: Suppression of cytochrome c oxidase II gene expression
21. Doxorubicin-induced chronic cardiotoxicity and its protection by liposomal administration
22. Protease activation during apoptosis: Death by a thousand cuts?
23. Doxorubicin cardiotoxicity is associated with alterations of plasma levels of atrial natriuretic factor
24. Doxorubicin selectively inhibits brain versus atrial natriuretic peptide gene expression in cultured neonatal rat myocytes
25. Persistent effects of doxorubicin on cardiac gene expression
26. A novel cardiac-restricted target for doxorubicin: CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes
27. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro
28. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats
29. Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice
30. Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study
31. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: Effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis
32. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats
33. New pharmacologic aspects of CS-866, the newest angiotensin II receptor antagonist